
|Articles|October 10, 2012
Two-drug combination best for melanoma
A two-drug combination for metastatic melanoma reduced the odds of progression by 60 percent, demonstrating more effectiveness than monotherapy, according to researchers.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: Hydrocolloid Pimple Patches
2
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
3
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
4
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
5











